Latest / Trenches in Transplant Surgery
Zimislecel - Stem Cell Therapy for Type 1 Diabetes
This podcast presents an original article detailing a phase 1-2 clinical study called VX-880-101 FORWARD, which investigates zimislecel as an allogeneic stem cell-derived islet-cell therapy for type 1 diabetes. The research aimed to assess the safety and efficacy of this new treatment, particularly its ability to restore physiologic islet function and potentially lead to insulin independence. The methods section outlines the study design, participant eligibility, and dosage regimens for zimislecel, administered via a single portal vein infusion, along with immunosuppressive therapy.
Results…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.